EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HLA Class I Haplotype in Glutamic Acid Decarboxylase Antibody‐Associated Neurological Disease

Lin Bai iD, Haitao Ren, Qiang Lu, Han Zhang, Yang Yu, Zhuo Yang, Xinzhuang Yang, Siyuan Fan iD, Xinhua Wan, Yicheng Zhu, Hongzhi Guan iD, Meng Xiao iD

European Journal of Neurology · 2026-05 · 33 (5)

DOI: 10.1111/ene.70619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 11.05.2026. Verfasst von Lin Bai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Autoantibodies, Autoimmune Diseases of the Nervous System, Genetic Predisposition to Disease, Glutamate Decarboxylase. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Object Glutamic acid decarboxylase antibody‐associated neurological disease (GADAND) is a rare autoimmune disorder with elusive immunogenetic underpinnings. We aimed to investigate HLA associations with GADAND susceptibility in a Chinese cohort.

Methods

We performed HLA genotyping at the HLA‐A, ‐B, ‐C, ‐DRB1, ‐DQA1, and ‐DQB1 loci in 62 Chinese patients with GADAND and compared them with 990 healthy controls. Haplotype frequencies were estimated using the expectation–maximization (EM) algorithm. Allele and haplotype associations with disease susceptibility and clinical phenotypes were assessed.

Results

We identified the HLA class I haplotype A*11:01 ~ B*40:01 ~ C*07:02 as a susceptibility haplotype for GADAND (OR = 10.22, 95% CI 3.86–25.57, p adj = 0.003), and the association was stronger for the extended haplotype including DQA1*01:03 (OR = 25.61, 95% CI 4.99–89.11, p adj < 0.001). Three haplotypes showed suggestive but non‐significant associations: B*44:02 ~ C*05:01 (OR = 8.32, 95% CI 2.52–24.48, p adj = 0.069), DQA1*01:03 ~ DQB1*06:01 ~ DRB1*08:03 (OR = 3.15, 95% CI 1.67–5.63, p adj = 0.066), and DQA1*05:05 ~ DQB1*03:01, which showed a suggestive protective effect (OR = 0.15, 95% CI 0.018–0.556, p adj = 0.088). T1DM risk haplotypes, including DQA1*03:01 ~ DQB1*03:02 ~ DRB1*04:03 (OR = 5.04, 95% CI 1.18–16.62, p adj = 0.744) and DQA1*05:01 ~ DQB1*02:01 ~ DRB1*03:01 (OR = 2.50, 95% CI 1.07–5.24, p adj = 0.829), were more frequent in GADAND patients, and A*11:01 ~ B*40:01 ~ C*07:02 was enriched in those with comorbid AITD. No statistically significant associations were identified between HLA haplotypes and clinical phenotypes.

Conclusions

The haplotype A*11:01 ~ B*40:01 ~ C*07:02 was associated with GADAND susceptibility in the Chinese population, implicating T cell involvement. T1DM‐associated haplotypes were overrepresented in GADAND, and A*11:01 ~ B*40:01 ~ C*07:02 was enriched in comorbid AITD, suggesting HLA as a shared immunogenetic basis for autoimmune comorbidities. No significant HLA associations with clinical phenotypes were identified, warranting validation in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesAutoimmune Diseases of the Nervous SystemGenetic Predisposition to DiseaseGlutamate DecarboxylaseHistocompatibility Antigens Class INervous System DiseasesAdultFemaleHumansMaleMiddle AgedHaplotypesChinaEast Asian People

Stichwörter der Autor:innen

HLA genesautoimmuneepilepsyglutamic acid decarboxylasestiff‐person syndrome

Substanzen

AutoantibodiesGlutamate DecarboxylaseHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Molecular Biology and Biochemistry, State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine…
  • Center for Bioinformatics, National Infrastructures for Translational Medicine, Institute of Clinical Medicine & Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Colleg…

ORCID-Profile: Lin Bai, Siyuan Fan, Hongzhi Guan, Meng Xiao

Förderung

  • National High Level Hospital Clinical Research Funding
  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

Zitieren

APA

Bai, L., Ren, H., Lu, Q., Zhang, H., Yu, Y., Yang, Z., Yang, X., Fan, S., Wan, X., Zhu, Y., Guan, H., & Xiao, M. (2026). HLA Class I Haplotype in Glutamic Acid Decarboxylase Antibody‐Associated Neurological Disease. European Journal of Neurology, 33(5). https://doi.org/10.1111/ene.70619

Vancouver

Bai L, Ren H, Lu Q, Zhang H, Yu Y, Yang Z, et al. HLA Class I Haplotype in Glutamic Acid Decarboxylase Antibody‐Associated Neurological Disease. European Journal of Neurology. 2026;33(5). doi:10.1111/ene.70619

BibTeX
@article{Bai2026,
  author = {Bai, Lin and Ren, Haitao and Lu, Qiang and Zhang, Han and Yu, Yang and Yang, Zhuo and Yang, Xinzhuang and Fan, Siyuan and Wan, Xinhua and Zhu, Yicheng and Guan, Hongzhi and Xiao, Meng},
  title = {HLA Class I Haplotype in Glutamic Acid Decarboxylase Antibody‐Associated Neurological Disease},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {5},
  doi = {10.1111/ene.70619}
}
Kostenlos starten →